{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20200227",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "61989",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761060s003lbl.pdf",
              "date": "20200228",
              "type": "Label"
            },
            {
              "id": "61990",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761060Orig1s003ltr.pdf",
              "date": "20200228",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180409",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "53657",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/761060Orig1s001ltr.pdf",
              "date": "20180412",
              "type": "Letter"
            },
            {
              "id": "53663",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761060s001lbl.pdf",
              "date": "20180412",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170901",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 4",
          "submission_class_code_description": "Type 4 - New Combination",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "49653",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761060lbl.pdf",
              "date": "20170901",
              "type": "Label"
            },
            {
              "id": "49679",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761060Orig1s000Orig2s000ltr.pdf",
              "date": "20170906",
              "type": "Letter"
            },
            {
              "id": "54475",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/761060Orig1s000Orig1Orig2s000TOC.html",
              "date": "20180608",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20200616",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "63575",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761060s004lbl.pdf",
              "date": "20200616",
              "type": "Label"
            },
            {
              "id": "63586",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761060Orig1s004ltr.pdf",
              "date": "20200617",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20170901",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "49678",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761060Orig1s000Orig2s000ltr.pdf",
              "date": "20170906",
              "type": "Letter"
            },
            {
              "id": "54476",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/761060Orig1s000Orig1Orig2s000TOC.html",
              "date": "20180608",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "BLA761060",
      "sponsor_name": "WYETH PHARMS INC",
      "openfda": {
        "application_number": [
          "BLA761060"
        ],
        "brand_name": [
          "MYLOTARG"
        ],
        "generic_name": [
          "GEMTUZUMAB OZOGAMICIN"
        ],
        "manufacturer_name": [
          "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
        ],
        "product_ndc": [
          "0008-4510"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "GEMTUZUMAB OZOGAMICIN"
        ],
        "rxcui": [
          "1944701",
          "1944704"
        ],
        "spl_id": [
          "ef242018-af2a-4c03-99b7-908e2610f86f"
        ],
        "spl_set_id": [
          "32fd2bb2-1cfa-4250-feb8-d7956c794e05"
        ],
        "package_ndc": [
          "0008-4510-01"
        ],
        "nui": [
          "N0000175571",
          "N0000175077"
        ],
        "pharm_class_epc": [
          "CD33-directed Immunoconjugate [EPC]"
        ],
        "pharm_class_moa": [
          "CD33-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "8GZG754X6M"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "MYLOTARG",
          "active_ingredients": [
            {
              "name": "GEMTUZUMAB OZOGAMICIN",
              "strength": "4.5MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "VIAL",
          "route": "SINGLE-DOSE",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}